83 related articles for article (PubMed ID: 20077288)
1. Toxicity due to excess and deficiency.
Aggett PJ
J Toxicol Environ Health A; 2010; 73(2):175-80. PubMed ID: 20077288
[TBL] [Abstract][Full Text] [Related]
2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
3. Essentiality and toxicity in copper health risk assessment: overview, update and regulatory considerations.
Stern BR
J Toxicol Environ Health A; 2010; 73(2):114-27. PubMed ID: 20077283
[TBL] [Abstract][Full Text] [Related]
4. Risks and benefits of copper in light of new insights of copper homeostasis.
de Romaña DL; Olivares M; Uauy R; Araya M
J Trace Elem Med Biol; 2011 Jan; 25(1):3-13. PubMed ID: 21342755
[TBL] [Abstract][Full Text] [Related]
5. Background to the ADI/TDI/PTWI.
Herrman JL; Younes M
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S109-13. PubMed ID: 10597623
[TBL] [Abstract][Full Text] [Related]
6. The effect of essentiality on risk assessment.
Becking GC
Biol Trace Elem Res; 1998; 66(1-3):423-38. PubMed ID: 10050935
[TBL] [Abstract][Full Text] [Related]
7. [The overall nutritional quality of the diet is reflected in the growth of Nigerian children].
Tarini A; Bakari S; Delisle H
Sante; 1999; 9(1):23-31. PubMed ID: 10210799
[TBL] [Abstract][Full Text] [Related]
8. Precision of estimates of an ADI (or TDI or PTWI).
Speijers GJ
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
[TBL] [Abstract][Full Text] [Related]
9. Toxicity assessment strategies, data requirements, and risk assessment approaches to derive health based guidance values for non-relevant metabolites of plant protection products.
Dekant W; Melching-Kollmuss S; Kalberlah F
Regul Toxicol Pharmacol; 2010 Mar; 56(2):135-42. PubMed ID: 19883711
[TBL] [Abstract][Full Text] [Related]
10. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds.
Pelekis M; Gephart LA; Lerman SE
Regul Toxicol Pharmacol; 2001 Feb; 33(1):12-20. PubMed ID: 11259175
[TBL] [Abstract][Full Text] [Related]
11. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
Kirman CR; Sweeney LM; Corley R; Gargas ML
Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
[TBL] [Abstract][Full Text] [Related]
12. Risk-benefit analysis of micronutrients.
Renwick AG; Flynn A; Fletcher RJ; Müller DJ; Tuijtelaars S; Verhagen H
Food Chem Toxicol; 2004 Dec; 42(12):1903-22. PubMed ID: 15500928
[TBL] [Abstract][Full Text] [Related]
13. Is the acceptable daily intake as presently used an axiom or a dogma?
Galli CL; Marinovich M; Lotti M
Toxicol Lett; 2008 Aug; 180(2):93-9. PubMed ID: 18588960
[TBL] [Abstract][Full Text] [Related]
14. Nutritional quality of the diets of US public school children and the role of the school meal programs.
Clark MA; Fox MK
J Am Diet Assoc; 2009 Feb; 109(2 Suppl):S44-56. PubMed ID: 19166672
[TBL] [Abstract][Full Text] [Related]
15. Feeding Infants and Toddlers Study: do vitamin and mineral supplements contribute to nutrient adequacy or excess among US infants and toddlers?
Briefel R; Hanson C; Fox MK; Novak T; Ziegler P
J Am Diet Assoc; 2006 Jan; 106(1 Suppl 1):S52-65. PubMed ID: 16376630
[TBL] [Abstract][Full Text] [Related]
16. Highest Observed Intake: definition, regulatory uses and provisional values.
Hathcock J; Kriengsinyos W
Regul Toxicol Pharmacol; 2011 Oct; 61(1):115-8. PubMed ID: 21802469
[TBL] [Abstract][Full Text] [Related]
17. Dietary exposure to copper in the European Union and its assessment for EU regulatory risk assessment.
Sadhra SS; Wheatley AD; Cross HJ
Sci Total Environ; 2007 Mar; 374(2-3):223-34. PubMed ID: 17270248
[TBL] [Abstract][Full Text] [Related]
18. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone.
Gentry PR; Covington TR; Clewell HJ; Anderson ME
J Toxicol Environ Health A; 2003 Dec; 66(23):2209-25. PubMed ID: 14612334
[TBL] [Abstract][Full Text] [Related]
19. A procedure for developing risk-based reference doses.
Gaylor DW; Kodell RL
Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
[TBL] [Abstract][Full Text] [Related]
20. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
